Preclinical Characterization of Antioxidant Quinolyl Nitrone QN23 as a New Candidate for the Treatment of Ischemic Stroke

Nitrones are encouraging drug candidates for the treatment of oxidative stress-driven diseases such as acute ischemic stroke (AIS). In a previous study, we found a promising quinolylnitrone, QN23, which exerted a neuroprotective effect in neuronal cell cultures subjected to oxygen–glucose deprivatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Alonso, Emma, Escobar-Peso, Alejandro, Aliena-Valero, Alicia, Torregrosa, Germán, Chioua, Mourad, Fernández-Serra, Rocío, González-Nieto, Daniel, Ouahid, Youness, Salom, Juan B., Masjuan, Jaime, Marco-Contelles, José, Alcázar, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220178/
https://www.ncbi.nlm.nih.gov/pubmed/35740081
http://dx.doi.org/10.3390/antiox11061186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220178/
https://www.ncbi.nlm.nih.gov/pubmed/35740081
http://dx.doi.org/10.3390/antiox11061186

Ejemplares similares